About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Acute Lymphoblastic Leukemia - Incidence

Last Updated on Jun 26, 2020
Font : A-A+

Incidence of Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia (ALL) can occur at all ages. However, it is most common in young children and older adults.

Advertisement

The incidence of Acute Lymphoblastic Leukemia (ALL) in Children below 15 years is approximately 3-4 cases per 100,000 children.

The following are some of the highlights of ALL incidence-

  • ALL is more prevalent in developed countries than in the developing ones. The magnitude of the disease appears to correlate with the socio-economic status.
  • There are approximately 2,400 children and adolescents below 20 years of age who are diagnosed with ALL each year in the United States.
  • A gradual increase in the incidence of ALL has been observed in the last 25 years.
  • ALL is the most common cancer among children with a peak incidence of 4-5 years of age. It accounts for 23% of childhood cancers (children younger than 15 years).
Advertisement
  • The incidence of ALL appears to be highest in Hispanic children; it is 3- fold higher for white children, aged 2-3 years, compared to black children of the same age
  • In adults, it is less common than Acute Myelogenous Leukemia (AML). In the United States, approximately 1000 new ALL cases occur in adults each year.
  • Only 20-40% of adults with ALL are cured with current treatment regimens
  • The highest incidence of ALL occurs in Italy, the United States, Switzerland, and Costa Rica
  • The annual rate of ALL occurrence is approximately 30 to 40 per million.

References:

  1. Pui CH. Acute lymphoblastic leukemia. Pediatr Clin North Am 1997; 4: 831-846.
  2. Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med 1998; 339: 605-615.
  3. Gurney JG, Severson RK, Davis S, Robinson L. Incidence of cancer in children in the United States. Cancer 1995; 75: 2186-2195.
  4. Young J, Gloeckler RL, Silverberg E, Horm J, Miller R. Cancer incidence, survival and mortality for children younger than age 15 years. Cancer 1986; 58: 598-602.

Citations   close

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dr. Reeja Tharu. (2020, June 26). Incidence of Acute Lymphoblastic Leukemia. Medindia. Retrieved on May 18, 2022 from https://www.medindia.net/patients/patientinfo/acute-lymphoblastic-leukemia-incidence.htm.

  • MLA

    Dr. Reeja Tharu. "Incidence of Acute Lymphoblastic Leukemia". Medindia. May 18, 2022. <https://www.medindia.net/patients/patientinfo/acute-lymphoblastic-leukemia-incidence.htm>.

  • Chicago

    Dr. Reeja Tharu. "Incidence of Acute Lymphoblastic Leukemia". Medindia. https://www.medindia.net/patients/patientinfo/acute-lymphoblastic-leukemia-incidence.htm. (accessed May 18, 2022).

  • Harvard

    Dr. Reeja Tharu. 2021. Incidence of Acute Lymphoblastic Leukemia. Medindia, viewed May 18, 2022, https://www.medindia.net/patients/patientinfo/acute-lymphoblastic-leukemia-incidence.htm.


Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.

Comments

manoj.c.p

hi my daughter , rashmi 5 year old female was admitted in a hospital with the c/o fever,and anemia diagnosed as a ALL ,B CELL,started chemotherapy there at the time of admission her haemoglobin is 4,platelet 10,000,peripheral smear shows blast presnt CSF NEGATIVE BONE MARROW NOT DONE induction chemotherapy started prednisolone oral inj.vincristine i.v 4 doses inj, daunorubicin 3 doses inj.L. asparaginase 8 doses IT ,methotrexate 3 times BONE MARRO DONE 3? BLAST SHOWS phase b inj.cyclophosphamide iv 2 time inj,cytarabine s/c [ arac] 4 days * 4 doses tab .6 mp 60 days IT METHOTREXATE 3 times tab.biotraxate RE INDUCTION PHASE tab.dexamethasone orally inj.vincristine iv 4 doses inj. dnr 4 doses inj.L .asparanginase 4 dose inj.cyclophosphamide 1 dose inj.cytarabine 2 dose it.methotrexate 2 doses BONE MARROW DONE SHOWS 3% BLASTS AND 5%LYMPHS CSF NEGATIVE given tab.6pm for one month review 20/8/2012 please given valuable comments how is the condition and what to do next?

satzjeez

DO A HEART PATIENT GET CLL OR ALL OR AML OR CML

Toni95

Non of this has helped me with my research :/ my sister has leukemia and none of the stuff above is even close!!

jasperkumar

i had ALL WEN I WAS 10. I was treated for a year and i was good for 10 years but i was diagnosed for ALL wen I WAS 20 . I was treated and i am okay now. is this possible?

ParisDaniels

I think the best way to combat is to educate yourself about it. This will help you recognize the symptoms and therefore prevent the spread of cancer cells. I appreciate you sharing this to us.

Advertisement
Health Topics A - Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z



    Advertisement
    What's New on Medindia
    Black Water: Benefits and Uses
    World Hypertension Day 2022 - Measure Blood Pressure Accurately, Control It, Live Longer!
    Drinking This Popular Beverage May Drop Dementia Risk
    View all
    Advertisement

    Medindia Newsletters Subscribe to our Free Newsletters!
    Terms & Conditions and Privacy Policy.

    Most Popular on Medindia

    Diaphragmatic Hernia Selfie Addiction Calculator Vent Forte (Theophylline) Turmeric Powder - Health Benefits, Uses & Side Effects Sinopril (2mg) (Lacidipine) Color Blindness Calculator Pregnancy Confirmation Calculator Find a Doctor The Essence of Yoga Hearing Loss Calculator

    Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

    © All Rights Reserved 1997 - 2022

    This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use